Patrick G. Enright, Director at Vera Therapeutics, Inc. (VERA), bought 5,882 shares at $42.50 ($250K) on 2025-12-11, disclosed to the SEC on 2025-12-15.
Open-market purchase of $250k VERA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VERA | BUY | 2025-06-25 | $10.6M | — | Filing → |
| BIOA | BUY | 2024-09-27 | $7.2M | — | Filing → |
| ZBIO | BUY | 2024-09-16 | $7.5M | — | Filing → |